Experienced in Transient Ischemic Attack (TIA)

Gary K. Hunter

5 Sheridan Street, 
Cairns, QLD, AU 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Transient Ischemic Attack (TIA)
5 Sheridan Street, 
Cairns, QLD, AU 
OverviewLocationsClinical Research

Overview

Gary Hunter practices in Cairns, Australia. Mr. Hunter is rated as an Experienced expert by MediFind in the treatment of Transient Ischemic Attack (TIA). His top areas of expertise are Stroke, Seizures, Epilepsy, Status Epilepticus, and Thrombectomy.

His clinical research consists of co-authoring 45 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles and participated in 1 clinical trial in the study of Transient Ischemic Attack (TIA).

Gender
Male

Locations

5 Sheridan Street, Cairns, QLD 4870, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

PROTEST Trial - PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury, a Double-blind Randomized Controlled Trial
PROTEST Trial - PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury, a Double-blind Randomized Controlled Trial
Enrollment Status: Recruiting
Publish Date: September 19, 2024
Intervention Type: Drug
Study Drug: Dalteparin
Study Phase: Phase 3
Multicentre, Prospective Randomized Open Label, Blinded-endpoint (PROBE) Controlled Trial of Thrombolysis With Low Dose Tenecteplase (TNK-tPA) Versus Standard of Care in Minor Ischemic Stroke With Proven Acute Symptomatic Occlusion
Multicentre, Prospective Randomized Open Label, Blinded-endpoint (PROBE) Controlled Trial of Thrombolysis With Low Dose Tenecteplase (TNK-tPA) Versus Standard of Care in Minor Ischemic Stroke With Proven Acute Symptomatic Occlusion
Enrollment Status: Completed
Publish Date: January 31, 2025
Intervention Type: Drug
Study Drugs: Tenecteplase, Antiplatelet Monotherapy
Study Phase: Phase 3
View 1 Less Clinical Trial

45 Total Publications

Brain Frailty and Functional Outcomes After Thrombolysis for Acute Ischemic Stroke.
Brain Frailty and Functional Outcomes After Thrombolysis for Acute Ischemic Stroke.
Journal: JAMA network open
Published: September 30, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Hunter's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile